<DOC>
	<DOCNO>NCT00731393</DOCNO>
	<brief_summary>The aim present study assess reactogenicity immunogenicity thiomersal-free influenza vaccine . For comparison , group subject administer standard formulation Influsplit SSW® 2003/2004 .</brief_summary>
	<brief_title>Immuno &amp; Reacto TF Trivalent Influenza Split Vaccine 2003/04 Std Formulation Influsplit SSW®/Fluarix™ 2003/04</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects whose parents/guardians investigator believe comply requirement protocol Male female child 6 month age time vaccination , yet 6 year old . All child include study must never give prophylactic influenza inoculation . Written consent vaccination must available parent single parent parents/guardians brief study understandable language . Use study unlicensed medication administration vaccine study vaccine within 30 day precede vaccination and/or study period 30 day administration second vaccine dose . Acute disease begin study Acute clinically significant change lung , cardiovascular system , liver kidney function , identify physical examination laboratory test . Known allergic reaction might cause one component vaccine . Administration immunoglobulins and/or blood product within 3 month begin study plan administration study period .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Thiomersal-free influenza split vaccine 2003/2004</keyword>
	<keyword>Influsplit SSW®/Fluarix™ 2003/2004</keyword>
	<keyword>Influenza</keyword>
</DOC>